Pfizer/BioNTech mRNA Combo Influenza and COVID Shot Efficacy Fails in Trial
Pfizer and BioNTech recently announced that a new mRNA vaccine designed to protect against both COVID-19 and influenza in a single shot faced a major setback after failing to achieve one of its primary goals in a late-stage trial. The “primary goal” missed in the late-stage trials was the ability to effectively prevent influenza B. […]
Risk of Infection Increases With Each mRNA COVID-19 Vaccine Dose, Study Shows
New research raises serious questions about the COVID-19 vaccine’s long-term effectiveness and potential role in increasing susceptibility to infection. In a recent peer-reviewed study published in Clinical Infectious Diseases, researchers found that the risk of COVID-19 increased as the number of vaccine doses increased and the vaccine became increasingly less effective against variants different from those […]
Coronavirus Test Swabs Contain Carcinogen Ethylene Oxide
Ethylene oxide (EtO) is primarily used to produce chemicals such as antifreeze. But in smaller quantities, EtO is also used as a pesticide as well as a sterilizing agent in medical settings.1 The ability of ethylene oxide to damage DNA is what makes it effective as a pesticide and sterilizing agent, but is also what […]
‘Does It Bother You?’: Rand Paul Questions Ex-CDC Director About Gain-Of-Function Research
[Dr. Anthony Fauci] said in 2012 that even if a pandemic should occur [as a result of gain-of-function research], the knowledge was worth it. So I guess my question to Dr. [Robert] Redfield was, do you think that taking a coronavirus—the backbone of a SARS coronavirus—and swapping out S proteins from unknown viruses… do you […]
Monkeypox Fear Fest: Is Smallpox Vaccine on Its Way Back?
This article is an excerpt from a longer fully referenced report by NVIC co-founder and president Barbara Loe Fisher on Mutated Monkeypox Outbreaks and the Anticipated Return of Smallpox Vaccine, which can be read on NVIC.org. A day before the July 4, 2024 holiday, Business Insider published an article warning that “Experts are racing to […]
U.S. Government Gives Moderna $176 Million to Develop mRNA Bird Flu Biologic
On July 2, 2024, the U.S. government awarded a $176 million contract to Moderna, Inc. for the development of an mRNA H5N1 avian influenza biologic labeled a “vaccine,” as the media reports concerns about bird flu in dairy cows and farm workers in multiple states. The funds from the U.S. Biomedical Advanced Research and Development […]